Research programme: cyclophilin ligands - Guilford Pharmaceuticals
Alternative Names: Cyclophilin ligandsLatest Information Update: 18 Jun 2004
At a glance
- Originator MGI GP
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Age-related macular degeneration; Neurological disorders
Most Recent Events
- 18 Jun 2004 Discontinued - Preclinical for Age-related macular degeneration in USA (unspecified route)
- 18 Jun 2004 Discontinued - Preclinical for Neurological disorders in USA (unspecified route)
- 17 Nov 2003 Preclinical trials in Age-related macular degeneration in USA (unspecified route)